Drug Trial Radar · NCT01451541
A Safety and Efficacy Study of Ciclesonide Nasal Aerosol in Subjects 6-11 Years With Perennial Allergic Rhinitis (PAR).
Last checked: Nov 19, 2026Latest source record: May 6, 2014 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
848
Actual
Start
Oct 2011
Primary completion
Dec 2012
Study completion Dec 2012
Sponsor
- Lead sponsor
- Sumitomo Pharma America, Inc.Industry
- Sponsor type
- Industry
- First posted
- Oct 13, 2011
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 6 years, up to 11 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a 12-week, multicenter, randomized, double-blind, placebo-controlled, parallel-group, efficacy and safety study of ciclesonide nasal aerosol administered once daily to male and premenarchal female subjects 6 to 11 years of age with a diagnosis of PAR.
Conditions
- Perennial Allergic Rhinitis
- PAR
Interventions
Ciclesonide nasal aerosol 37 mcgDrug
ciclesonide nasal aerosol 37mcg - the dose is administered as 1 actuation per nostril to give a total dose of 37
ciclesonide nasal aerosol 74 mcgDrug
ciclesonide nasal aerosol 74 mcg - the dose is administered as 1 actuation per nostril to give a total dose of 74 mcg
PlaceboDrug
Placebo - one dose per nostril
Primary outcomes
What the sponsor says the trial is designed to measure.
- The Change From Baseline in Average Daily Subject-reported AM and PM Reflective Total Nasal Symptom Scores (rTNSS) Averaged Weekly Over the First 6 Weeks of the Double-blind Treatment.Time frame: Weeks 0-6
Locations
60 sites in 1 country. Site status is shown where the registry gives one.
Burke Pharmaceutical Research
Hot Springs, Arkansas
Arkansas Pediatric Clinic
Little Rock, Arkansas
West Coast Clinical Trials, LLC
Costa Mesa, California
Premier Health Research Center
Downey, California
Allergy and Asthma Specialists Medical Group
Huntington Beach, California
Pediatric Care Medical Group
Huntington Beach, California
Allergy and Asthma Assoc of Southern CA
Mission Veijo, California
Center for Clinical Trials, LLC
Paramount, California
Allergy Associates Medical Group
San Diego, California
Allergy and Asthma Medical Group & Research Center
San Diego, California
Sansum Clinic
Santa Barbara, California
Colorado Allergy and Asthma Centers, PC
Centennial, Colorado
IMMUNOe International Research Centers
Centennial, Colorado
Storms Clinical Research Institute
Colorado Springs, Colorado
Ashtma and Allergy Associates
Pueblo, Colorado
DataQuest Medical Research, LLC
Lawerenceville, Georgia
Aeroallergy Research Labs of Savannah
Savannah, Georgia
Atlanta Allergy and Asthma Clinic
Stockbridge, Georgia
Clinical Research Atlanta
Stockton, Georgia
Sneeze, Wheeze, & Itch Associates, LLC
Normal, Illinois
College Park Family Care Center
Lenexa, Kansas
Family Allergy and Asthma Research Institute
Louisville, Kentucky
Gordon Raphael, MD
Bethesda, Maryland
Northeast Medical Research Associates Inc
North Dartmouth, Massachusetts
Respiratory Medicine Research Institute of Michigan, PLC
Ypsilanti, Michigan
Clinical Research Institute Inc
Plymouth, Minnesota
Clinical Research of the Ozarks
Warrensburg, Missouri
Clinical Research Group of Montana
Bozeman, Montana
The Asthma and Allergy Center, PC
Bellevue, Nebraska
Boys Town National Research Hospital
Boys Town, Nebraska
Atlantic Research Center LLC
Ocean City, New Jersey
Island Medical Research P.C.
Rockville Centre, New York
Allergy and Asthma Center of NC, PA
High Point, North Carolina
Catalyst Medical Center
Fargo, North Dakota
Sterling Research Group Ltd
Cincinnati, Ohio
Toledo Center for Clinical Research
Sylvania, Ohio
Allergy, Asthma & Clinical Research Center
Oklahoma City, Oklahoma
Amy Darter, MD
Oklahoma City, Oklahoma
Cyn3rgy Research
Gresham, Oregon
Baker Allergy Asthma and Dermatolgy Research Center, LLC
Lake Oswego, Oregon
Showing 40 of 60 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.